Loading
-
( Your local time: - )
Head to the registration desk to pick up your name badge and your personalised agenda from one of our friendly team. Feel free to ask us any questions you might have about the day ahead! -
( Your local time: - )
• How intensified processing, digital tools and new formats are changing what a competitive process looks like • Where European development and manufacturing can win as the US off shores and Asia expa … -
( Your local time: - )Establishing platform processes and identifying when molecule-specific approaches are needed Cell line selection, clone development and early process optimisation Building scalability and technology t …
-
( Your local time: - )What to invest in before first-in-human and what can wait Stopping CMC becoming the rate-limiting step on accelerated programmes Aligning development, quality and regulatory teams on risk
-
( Your local time: - )Controlling viscosity, aggregation and stability at high concentration Excipient and formulation strategies that keep injection volumes low Moving products from intravenous to subcutaneous administrat …
-
( Your local time: - )• Multi-column chromatography and in-line conditioning in practice • Connecting upstream and downstream into an integrated process • The business case: footprint, resin use and cost of goods
-
( Your local time: - )• Where robotics and intelligent automation are delivering today • Reducing manual intervention while improving consistency • What still needs a human in the loop, and why
-
( Your local time: - )
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers. -
( Your local time: - )
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers. -
( Your local time: - )
Grab a refreshing beverage and tasty snack to power you through the next round of expertly curated roundtables, led by our industry partners. -
( Your local time: - )• Choosing between fed-batch, intensified fed-batch and perfusion • Media, cell line and equipment strategies for high-density culture • Scaling intensified processes while protecting product quality
-
( Your local time: - )• Selecting next-generation resins, membranes and filtration technologies for complex biologics • Improving clearance of aggregates, fragments and product-related impurities • Integrating novel purifi …
-
( Your local time: - )• Designing comparability studies for process, site and scale changes • Using established conditions and lifecycle management tools • Managing changes efficiently across multiple regulatory regions
-
( Your local time: - )• Matching formulation to device early in development • Meeting EU requirements for drug-device combination products • Enabling large-volume subcutaneous delivery
-
( Your local time: - )• Using digital twins to model and optimise manufacturing processes • Advancing predictive process control • Enabling real-time release and continuous process monitoring
-
( Your local time: - )
Retreat to the on-site restaurant, where you will be treated to a delicious lunch menu featuring a selection of dishes freshly prepared for you. -
( Your local time: - )• Intensified and continuous processing from development to commercial scale • Shortening the path from cell line to clinic • Building quality and scalability in from the start
-
( Your local time: - )
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers. -
( Your local time: - )
Dedicated time reserved for your pre-booked 1:1 meetings with our event partners and / or to networking with your senior industry peers. -
( Your local time: - )• High-concentration and device-led subcutaneous delivery • Sterile manufacturing under tighter European requirements • Sustainability across packaging, cold chain and supply
-
( Your local time: - )
Grab a quick beverage and delicious snack to power you through the exciting afternoon sessions. Don't forget to network and make a new connection. -
( Your local time: - )Addressing mispairing, aggregation, low titres and other molecule-specific challenges Adapting established upstream process platforms for complex biologic formats Integrating developability assessment …
-
( Your local time: - )Putting a contamination control strategy into practice Isolators, barrier systems and upgrading legacy lines Fill-finish capacity and choosing a manufacturing partner
-
( Your local time: - )Where expectations diverge and how to plan for it Using scientific advice and early dialogue effectively Sequencing submissions without duplicating work
-
( Your local time: - )• Addressing manufacturing capacity constraints and investment priorities across Europe • Improving manufacturing efficiency and cost of goods for biosimilars and high-volume biologics • Reducing supp …
-
( Your local time: - )• Establishing effective model governance and lifecycle management • What the EU AI Act and regulator guidance mean for GMP use • Building confidence in AI-generated and AI-assisted outputs
-
( Your local time: - )• The capacity race: where Europe's CDMOs and manufacturers are investing next • What it really takes to scale a biologics operation, and what goes wrong • The decisions development teams should make …
-
( Your local time: - )
Relax at the end of a highly productive day, grab a cool, refreshing beverage and a delicious snack, and catch up with colleagues and newly formed connections to reflect on the day.